journal article·2016-10-02Open access

Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art

Mahfoozur Rahman, Vikas Kumar, Sarwar Beg, Gajanand Sharma, Om Prakash Katare, Firoz Anwar

Abstract

Inflammatory diseases are considered to be highly dreadful ones responsible for higher mortality in the developed countries. This includes cancer, psoriasis, rheumatoid arthritis, and inflammatory bowel disease. The tremendous strides in the area of drug development to find newer molecules like non-steroidal and steroidal agents and immunosuppressant agents delivered by conventional formulation. These therapy have enhances the life expectancy of patient, but it provide the therapeutic benefits only to a limited extent. Recent advancement in liposomes based nanomedicines has led to the possibility of improves the efficacy and safety of the pharmacotherapy of inflammatory disorders. Of late, liposomes have been highly explored as one of the promising systems for delivering numerous anti-inflammatory drugs for attaining enhanced therapeutic outcomes. Over the conventional carriers, liposomal systems have numerous drug delivery merits including advantages in both passive and active targeting of drug molecules to the inflammatory lesions. The current review article, therefore, endeavors to provide a bird's eye view account on the success of liposome-based therapeutic systems in the management of dreadful inflammatory disorders along with updated knowledge to pharmaceutical scientists in the field.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Monoclonal and Polyclonal Antibodies Research · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology & Sciences (SHIATS), Allahabad, India

Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

Liposome Research Laboratory, UIPS, Panjab University, Chandigarh, Mumbai, India

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

References (85)

Show source-provided references
1. 10.1016/j.jconrel.2009.02.02310.1016/j.jconrel.2009.02.023 ↗
2. 10.1016/S0378-5173(01)00810-910.1016/S0378-5173(01)00810-9 ↗
3. 10.1111/j.1346-8138.2002.tb00321.x10.1111/j.1346-8138.2002.tb00321.x ↗
4. 10.2174/138920021666615081212212810.2174/1389200216666150812122128 ↗
5. 10.2174/156800961131304000210.2174/1568009611313040002 ↗
6. 10.1517/17425247.2012.71682410.1517/17425247.2012.716824 ↗
7. 10.2174/13816121179639100110.2174/138161211796391001 ↗
8. 10.1016/j.canlet.2004.03.03810.1016/j.canlet.2004.03.038 ↗
9. Ali MF · Med Sci Monit · 2008 · 12 · I66
10. 10.1021/bi00832a03810.1021/bi00832a038 ↗
11. 10.1016/S0022-2836(64)80115-710.1016/S0022-2836(64)80115-7 ↗
12. 10.1016/S0022-2836(65)80093-610.1016/S0022-2836(65)80093-6 ↗
13. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
14. Bhatia A · J Pharm Pharm Sci · 2004 · 7 · 252
15. 10.3109/10837450.2013.76326010.3109/10837450.2013.763260 ↗
16. 10.1007/BF0054137810.1007/BF00541378 ↗
17. 10.1677/erc.1.0076610.1677/erc.1.00766 ↗
18. 10.1016/j.jconrel.2006.02.01110.1016/j.jconrel.2006.02.011 ↗
19. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
20. Cleland LG · J Rheumatol Suppl · 1979 · 5 · 154
21. 10.1023/A:100757710196410.1023/A:1007577101964 ↗
22. Cotran RS · Am J Pathol · 1964 · 45 · 261
23. 10.1038/nature0132210.1038/nature01322 ↗
24. 10.1016/S0076-6879(05)91022-710.1016/S0076-6879(05)91022-7 ↗
25. 10.1080/1522795029009760610.1080/15227950290097606 ↗
26. 10.1016/S0140-6736(79)91951-210.1016/S0140-6736(79)91951-2 ↗
27. 10.1016/j.colsurfb.2009.07.00510.1016/j.colsurfb.2009.07.005 ↗
28. 10.3109/0898210090303026310.3109/08982100903030263 ↗
29. 10.4161/cbt.5.1.234610.4161/cbt.5.1.2346 ↗
30. 10.1016/j.ijpharm.2009.04.02510.1016/j.ijpharm.2009.04.025 ↗
31. 10.1111/jgh.1275110.1111/jgh.12751 ↗
32. 10.1111/j.2042-7158.1993.tb05533.x10.1111/j.2042-7158.1993.tb05533.x ↗
33. 10.1016/j.bbamem.2006.05.02810.1016/j.bbamem.2006.05.028 ↗
34. Funk M, Schulze B, Guenzi E, Michaelis U, Bohnenkamp H, Eichhorn M, Schmitt-Sody M. 2007. Cationic liposomal preparations for the treatment of rheumatoid arthritis. WO/2007/134819; PCT/EP2007/004467.
35. 10.1038/bjc.1996.62510.1038/bjc.1996.625 ↗
36. 10.1211/jpp.59.1.001810.1211/jpp.59.1.0018 ↗
37. 10.1159/00025056210.1159/000250562 ↗
38. 10.2217/17435889.1.3.29710.2217/17435889.1.3.297 ↗
39. 10.1016/j.biomaterials.2015.02.00410.1016/j.biomaterials.2015.02.004 ↗
40. 10.1021/mp049909510.1021/mp0499095 ↗
41. 10.1023/B:PHAM.0000019298.29561.cd10.1023/B:PHAM.0000019298.29561.cd ↗
42. 10.1080/1061186060064842910.1080/10611860600648429 ↗
43. 10.1517/1742524090342794010.1517/17425240903427940 ↗
44. 10.1007/s11095-005-5376-310.1007/s11095-005-5376-3 ↗
45. 10.1002/art.2187610.1002/art.21876 ↗
46. 10.1016/j.jconrel.2012.06.02110.1016/j.jconrel.2012.06.021 ↗
47. 10.1021/bi962148u10.1021/bi962148u ↗
48. 10.1002/jps.102310.1002/jps.1023 ↗
49. 10.3390/ijms15091528710.3390/ijms150915287 ↗
50. 10.1111/j.2042-7158.1993.tb05603.x10.1111/j.2042-7158.1993.tb05603.x ↗
51. 10.1016/j.jconrel.2004.08.00710.1016/j.jconrel.2004.08.007 ↗
52. 10.18433/J3CP5510.18433/J3CP55 ↗
53. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
54. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
55. 10.1002/art.1114010.1002/art.11140 ↗
56. 10.1016/j.progsolidstchem.2005.11.01010.1016/j.progsolidstchem.2005.11.010 ↗
57. 10.1038/mt.2011.17410.1038/mt.2011.174 ↗
58. 10.1016/j.tibtech.2013.09.00710.1016/j.tibtech.2013.09.007 ↗
59. 10.1038/sj.bjc.660034410.1038/sj.bjc.6600344 ↗
60. 10.1093/emboj/19.13.315910.1093/emboj/19.13.3159 ↗
61. 10.1016/j.ejpb.2011.02.01610.1016/j.ejpb.2011.02.016 ↗
62. 10.1517/17425247.2012.66852210.1517/17425247.2012.668522 ↗
63. 10.2174/15701631280330589810.2174/157016312803305898 ↗
64. 10.1517/17425247.2015.98208810.1517/17425247.2015.982088 ↗
65. 10.2174/187791230566615061621580010.2174/1877912305666150616215800 ↗
66. 10.2174/15701631279930451610.2174/157016312799304516 ↗
67. 10.1046/j.1365-2133.1999.02927.x10.1046/j.1365-2133.1999.02927.x ↗
68. 10.1111/cei.1247110.1111/cei.12471 ↗
69. 10.1016/j.ijpharm.2013.03.00610.1016/j.ijpharm.2013.03.006 ↗
70. 10.1615/CritRevTherDrugCarrierSyst.201501109510.1615/CritRevTherDrugCarrierSyst.2015011095 ↗
71. 10.1126/science.247015210.1126/science.2470152 ↗
72. 10.1081/DDC-10010035910.1081/DDC-100100359 ↗
73. 10.1016/j.ijpharm.2007.06.01010.1016/j.ijpharm.2007.06.010 ↗
74. 10.1016/j.jconrel.2013.03.03610.1016/j.jconrel.2013.03.036 ↗
75. 10.1002/jps.260081020610.1002/jps.2600810206 ↗
76. 10.1016/S0140-6736(64)91804-510.1016/S0140-6736(64)91804-5 ↗
77. 10.1016/S0378-5173(02)00266-110.1016/S0378-5173(02)00266-1 ↗
78. 10.1080/1061186070172519110.1080/10611860701725191 ↗
79. 10.1021/mp200074210.1021/mp2000742 ↗
80. 10.1038/sj.bjp.070277610.1038/sj.bjp.0702776 ↗
81. 10.1016/j.jconrel.2004.02.00310.1016/j.jconrel.2004.02.003 ↗
82. 10.1016/j.biomaterials.2013.12.02410.1016/j.biomaterials.2013.12.024 ↗
83. 10.1016/S0142-9612(01)00267-810.1016/S0142-9612(01)00267-8 ↗
84. 10.1016/j.canlet.2012.11.03110.1016/j.canlet.2012.11.031 ↗
85. 10.1016/j.biomaterials.2013.01.07810.1016/j.biomaterials.2013.01.078 ↗